Funding
Accelerator investment · Healthtech

BGV backs CrossSense's smart glasses companion for dementia

CrossSense develops an AI companion for smart glasses that guides people with dementia through everyday activities at home.

By RoundOS Funding desk

CrossSense joined Bethnal Green Ventures' Spring 2026 investment portfolio, announced on April 21. The backing comes through BGV's Tech for Good programme, which combines early equity investment with support for founders.

Guidance in everyday tasks

CrossSense is developing Wispy, an AI companion for smart glasses that offers prompts and step-by-step guidance during household activities. The company works with people living with dementia and carers to adapt support to users' routines.

Funding history

Accelerator investment · This roundUndisclosed
Longitude Prize on Dementia£1MMindset XR grantUndisclosed

Sources

  1. Announcing our Spring 2026 cohortbethnalgreenventures.com · Apr 21, 2026
  2. crosssense.com

Similar rounds

All Healthtech rounds →
Nanochap

Develops retinal and cortical brain-computer interfaces that use electrical stimulation to create artificial visual perception.

CN¥500MSeries C+ · Nov 3, 2026
1nhaler

1nhaler develops a compact, single-dose dry powder inhaler made predominantly from cardboard.

£2.2MFollow-on funding · Nov 3, 2026
Esonitro

Esonitro develops flexible neural electrodes and brain-computer interface technology, including its movable NeuroWorm electrode.

~CN¥100MAngel+ · Nov 2, 2026
OBSESS

OBSESS connects people with sports venues, gyms, trainers, nutrition providers and fitness brands through a shared digital marketplace.

~₹30MAngel · Nov 2, 2026

Related